{"id":1022526,"date":"2026-11-19T07:33:11","date_gmt":"2026-11-19T12:33:11","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/zoetis-receives-usda-license-for-poulvac-procerta-hvt-nd-ilt-vaccine-for-chickens\/"},"modified":"2026-11-19T07:33:11","modified_gmt":"2026-11-19T12:33:11","slug":"zoetis-receives-usda-license-for-poulvac-procerta-hvt-nd-ilt-vaccine-for-chickens","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/zoetis-receives-usda-license-for-poulvac-procerta-hvt-nd-ilt-vaccine-for-chickens\/","title":{"rendered":"Zoetis Receives USDA License for Poulvac\u00ae Procerta\u00ae HVT-ND-ILT Vaccine for Chickens"},"content":{"rendered":"<p>        <!--.bwalignc { text-align: center; list-style-position: inside }\n.bwlistdisc { list-style-type: disc }\n.bwuline { text-decoration: underline }body {font:normal small Arial,Helvetica,sans-serif;color:#000;background-color:#fff;padding:24px;margin:0;} a img {border:0;} h3 {font-size:medium;color:#000;margin:0 0 1em 0; text-align:center;}-->  <\/p>\n<p class=\"bwalignc\"><b>Zoetis Receives USDA License for Poulvac\u00ae Procerta\u00ae HVT-ND-ILT Vaccine for Chickens<\/b><\/p>\n<p class=\"bwalignc\"><strong><i>3-in-1 vector vaccine expands disease-protection options for chickens, backed by Zoetis\u2019 comprehensive vaccine portfolio and specialized expertise<\/i><\/strong>\u00a0<\/p>\n<ul class=\"bwlistdisc\">\n<li><b>What it protects against:<\/b> Poulvac\u00ae Procerta\u00ae HVT-ND-ILT is designed to protect chickens against Marek\u2019s disease (MD), Newcastle disease (ND) and infectious laryngotracheitis (ILT).<sup> 1<\/sup><\/li>\n<li><b>Why it matters:<\/b> The USDA license adds a new option for veterinarians and poultry producers to consider when developing flock-health programs.\n<\/li>\n<\/ul>\n<p>PARSIPPANY, N.J.&#8211;(<a href=\"http:\/\/www.businesswire.com\">BUSINESS WIRE<\/a>)&#8211;<a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.zoetis.com%2F&amp;esheet=54643864&amp;newsitemid=20261118551715&amp;lan=en-US&amp;anchor=Zoetis+Inc.&amp;index=1&amp;md5=3593121f62e50af6bd5f9476f82749f7\">Zoetis Inc.<\/a> (NYSE: ZTS) today announced that the U.S. Department of Agriculture (USDA) has licensed Poulvac\u00ae Procerta\u00ae HVT-ND-ILT, a vector vaccine for chickens. The license marks an important milestone in Zoetis\u2019 continued investment and industry leadership in poultry health, disease protection, and innovation. Poulvac Procerta HVT-ND-ILT brings three disease targets together in one vaccine and expands the tools available to poultry veterinarians and producers as they develop vaccination programs.<\/p>\n<p>\n\u201cThe USDA license is an important achievement for our poultry business and reflects Zoetis\u2019 commitment to advancing practical solutions for customers,\u201d said Abhay Nayak, Executive Vice President and President, U.S. Commercial Operations at Zoetis. \u201cPoulvac Procerta HVT-ND-ILT adds a new option to our portfolio, giving veterinarians and producers more flexibility to tailor their vaccination strategies. Our team looks forward to working with customers as they consider how it may support their flock-health programs.\u201d<\/p>\n<p><b>3-in-1 protection veterinarians can count on<\/b><\/p>\n<p>\nILT remains an economically significant respiratory disease, with outbreaks capable of causing significant losses in flocks.<sup> 2<\/sup> Poulvac Procerta HVT-ND-ILT is designed to provide early, long-lasting protection against Marek\u2019s disease (MD), Newcastle disease (ND) and infectious laryngotracheitis (ILT).<sup> 1<\/sup> It is labeled for administration to healthy one-day-old chickens or 18- to 19-day-old embryonated chicken eggs.<\/p>\n<p><b>More flexibility in vaccination programs<\/b><\/p>\n<p>\nZoetis\u2019 poultry vaccine portfolio gives veterinarians options to build vaccination programs around flock needs and disease challenges. Poulvac Procerta HVT-ND-ILT can be included in seasonal or rotational ILT programs that also use modified-live vaccines. It complements other Poulvac\u00ae hatchery and immune-complex vaccines designed to address additional disease challenges, including infectious bursal disease, infectious bronchitis, Salmonella and <i>E. coli<\/i>.<\/p>\n<p><b>Support beyond the vaccine<\/b><\/p>\n<p>\nZoetis poultry specialists support customers by helping plan and implement targeted vaccination programs that optimize bird health and well-being. Tailored support can include technical guidance, diagnostic testing and analysis, hatchery services and team training, as well as vaccine audits and flock-health assessments.<\/p>\n<p><b>About Zoetis<\/b><\/p>\n<p>\nZoetis is the world\u2019s leading animal health company, driven by a singular purpose: to nurture our world and humankind by advancing care for animals. With a legacy of nearly 75 years, Zoetis continues to pioneer ways to predict, prevent, detect, and treat animal illness, supporting veterinarians, livestock producers, and pet owners in over 100 countries. We integrate deep scientific expertise, data-driven R&amp;D, advanced manufacturing, and commercial excellence to deliver meaningful innovation across medicines, vaccines, diagnostics, biopharmaceuticals, and digital solutions. Guided by our vision to be the most trusted and valued animal health company, Zoetis is committed to setting new standards for the future of animal care through innovation, customer obsession, and purpose-driven colleagues. To learn more, visit <a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.zoetis.com%2F&amp;esheet=54643864&amp;newsitemid=20261118551715&amp;lan=en-US&amp;anchor=Zoetis.com&amp;index=2&amp;md5=0cc12de8bd3263de3d9f59cfe231132f\">Zoetis.com<\/a>.<\/p>\n<p><i><span class=\"bwuline\">DISCLOSURE NOTICES<\/span><\/i><\/p>\n<p><i>Forward-Looking Statements: This press release contains forward-looking statements which reflect the current views of Zoetis with respect to expectations regarding products, product approvals or licenses, products under development and other future events. These statements are not guarantees of future performance or actions. Forward-looking statements are subject to risks and uncertainties. If one or more of these risks or uncertainties materialize, or if management&#8217;s underlying assumptions prove to be incorrect, actual results may differ materially from those contemplated by a forward-looking statement. Forward-looking statements speak only as of the date on which they are made. Zoetis expressly disclaims any obligation to update or revise any forward-looking statement, whether as a result of new information, future events or otherwise. A further list and description of risks, uncertainties and other matters can be found in our most recent Annual Report on Form 10-K, including in the sections thereof captioned \u201cForward-Looking Statements and Factors That May Affect Future Results\u201d and \u201cItem 1A. Risk Factors,\u201d in our Quarterly Reports on Form 10-Q and in our Current Reports on Form 8-K. These filings and subsequent filings are available online at <\/i><a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.sec.gov%2F&amp;esheet=54643864&amp;newsitemid=20261118551715&amp;lan=en-US&amp;anchor=www.sec.gov&amp;index=3&amp;md5=569f5b9f5031dfd25d4003a44e210558\"><i>www.sec.gov<\/i><\/a><i>, <\/i><a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.zoetis.com%2F&amp;esheet=54643864&amp;newsitemid=20261118551715&amp;lan=en-US&amp;anchor=www.zoetis.com&amp;index=4&amp;md5=1c10c94fa0eb25295eba0ab7ce282080\"><i>www.zoetis.com<\/i><\/a><i>, or on request from Zoetis.<\/i><\/p>\n<p><i>ZTS-COR<br \/>\n<br \/><\/i><i>ZTS-IR<br \/>\n<br \/><\/i><i>ZTS-FA<br \/>\n<br \/><\/i><i>ZTS-PS<\/i><\/p>\n<p><sup>1<\/sup> Data on file, Study Report Nos. B812R-US-23-J35, B812R-US-23-J78, B812R-US-22-G31, B812R-US-23-H50, B812R-US-23-H87, B814R-US-23-J69, B814R-US-24-K41, Zoetis Inc.<br \/>\n<br \/><sup>2 <\/sup><i>Journal of Animal Science<\/i>, Volume 98, Issue Supplement_1, August 2020, Pages S27\u2013S35, <a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fdoi.org%2F10.1093%2Fjas%2Fskaa133&amp;esheet=54643864&amp;newsitemid=20261118551715&amp;lan=en-US&amp;anchor=https%3A%2F%2Fdoi.org%2F10.1093%2Fjas%2Fskaa133&amp;index=5&amp;md5=a608b5d47ff512c1827c7f1ce87420e6\">https:\/\/doi.org\/10.1093\/jas\/skaa133<\/a><\/p>\n<p>\nAll trademarks are the property of Zoetis Services LLC or a related company or a licensor unless otherwise noted. \u00a9 2026 Zoetis Services LLC. All rights reserved. BIO-00524<\/p>\n<p><img decoding=\"async\" alt=\"\" src=\"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20261118551715r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\" style=\"width:0;height:0\" \/><span class=\"bwct31415\" \/><\/p>\n<p id=\"mmgallerylink\"><span id=\"mmgallerylink-phrase\">View source version on businesswire.com: <\/span><span id=\"mmgallerylink-link\"><a href=\"https:\/\/www.businesswire.com\/news\/home\/20261118551715\/en\/\" rel=\"nofollow\">https:\/\/www.businesswire.com\/news\/home\/20261118551715\/en\/<\/a><\/span><\/p>\n<p><span class=\"bwuline\">Media Contacts<\/span>:\u2003\u2003\u2003\u2003<br \/>\n<br \/>Leah Coyle \u2003\u2003<br \/>\n<br \/>862-202-3560 (c)\u2003\u2003\u2003\u2003<br \/>\n<br \/><a rel=\"nofollow\" href=\"mailto:leah.coyle@zoetis.com\">leah.coyle@zoetis.com<\/a> \u2003<\/p>\n<p>Jennifer Albano<br \/>\n<br \/>862-399-0810 (o)<br \/>\n<br \/><a rel=\"nofollow\" href=\"mailto:jennifer.albano@zoetis.com\">jennifer.albano@zoetis.com<br \/>\n<\/a><\/p>\n<p><span class=\"bwuline\">Investor Contacts<\/span>:<br \/>\n<br \/>Mathieu Aussermeier\u00a0<br \/>\n<br \/>862-460-0181 (o)\u00a0\u00a0<br \/>\n<br \/><a rel=\"nofollow\" href=\"mailto:mathieu.aussermeier@zoetis.com\">mathieu.aussermeier@zoetis.com<br \/>\n<\/a><\/p>\n<p>Nick Soonthornchai\u00a0<br \/>\n<br \/>973-443-2792 (o)<br \/>\n<br \/><a rel=\"nofollow\" href=\"mailto:nick.soonthornchai@zoetis.com\">nick.soonthornchai@zoetis.com<\/a><\/p>\n<p><b>KEYWORDS:<\/b> New Jersey United States North America<\/p>\n<p><b>INDUSTRY KEYWORDS:<\/b> Veterinary Infectious Diseases FDA Cardiology Biotechnology Other Health Health Pharmaceutical General Health<\/p>\n<p><b>MEDIA:<\/b><\/p>\n<table cellpadding=\"3\" cellspacing=\"3\">\n<tr>\n<td><font face=\"Arial\" size=\"2\"><b>Logo<\/b><\/font><\/td>\n<\/tr>\n<tr>\n<td><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20261118551715\/en\/404170\/3\/Zoetis_c.jpg\" alt=\"Logo\" \/><\/td>\n<\/tr>\n<tr>\n<td><font face=\"Arial\" size=\"2\"><\/font><\/td>\n<\/tr>\n<\/table>\n","protected":false},"excerpt":{"rendered":"<p>Zoetis Receives USDA License for Poulvac\u00ae Procerta\u00ae HVT-ND-ILT Vaccine for Chickens 3-in-1 vector vaccine expands disease-protection options for chickens, backed by Zoetis\u2019 comprehensive vaccine portfolio and specialized expertise\u00a0 What it protects against: Poulvac\u00ae Procerta\u00ae HVT-ND-ILT is designed to protect chickens against Marek\u2019s disease (MD), Newcastle disease (ND) and infectious laryngotracheitis (ILT). 1 Why it matters: The USDA license adds a new option for veterinarians and poultry producers to consider when developing flock-health programs. PARSIPPANY, N.J.&#8211;(BUSINESS WIRE)&#8211;Zoetis Inc. (NYSE: ZTS) today announced that the U.S. Department of Agriculture (USDA) has licensed Poulvac\u00ae Procerta\u00ae HVT-ND-ILT, a vector vaccine for chickens. The license marks an important milestone in Zoetis\u2019 continued investment and industry leadership in poultry health, disease protection, and innovation. Poulvac Procerta &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/zoetis-receives-usda-license-for-poulvac-procerta-hvt-nd-ilt-vaccine-for-chickens\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Zoetis Receives USDA License for Poulvac\u00ae Procerta\u00ae HVT-ND-ILT Vaccine for Chickens&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-1022526","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.9 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Zoetis Receives USDA License for Poulvac\u00ae Procerta\u00ae HVT-ND-ILT Vaccine for Chickens - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/zoetis-receives-usda-license-for-poulvac-procerta-hvt-nd-ilt-vaccine-for-chickens\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Zoetis Receives USDA License for Poulvac\u00ae Procerta\u00ae HVT-ND-ILT Vaccine for Chickens - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"Zoetis Receives USDA License for Poulvac\u00ae Procerta\u00ae HVT-ND-ILT Vaccine for Chickens 3-in-1 vector vaccine expands disease-protection options for chickens, backed by Zoetis\u2019 comprehensive vaccine portfolio and specialized expertise\u00a0 What it protects against: Poulvac\u00ae Procerta\u00ae HVT-ND-ILT is designed to protect chickens against Marek\u2019s disease (MD), Newcastle disease (ND) and infectious laryngotracheitis (ILT). 1 Why it matters: The USDA license adds a new option for veterinarians and poultry producers to consider when developing flock-health programs. PARSIPPANY, N.J.&#8211;(BUSINESS WIRE)&#8211;Zoetis Inc. (NYSE: ZTS) today announced that the U.S. Department of Agriculture (USDA) has licensed Poulvac\u00ae Procerta\u00ae HVT-ND-ILT, a vector vaccine for chickens. The license marks an important milestone in Zoetis\u2019 continued investment and industry leadership in poultry health, disease protection, and innovation. Poulvac Procerta &hellip; Continue reading &quot;Zoetis Receives USDA License for Poulvac\u00ae Procerta\u00ae HVT-ND-ILT Vaccine for Chickens&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/zoetis-receives-usda-license-for-poulvac-procerta-hvt-nd-ilt-vaccine-for-chickens\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2026-11-19T12:33:11+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20261118551715r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/zoetis-receives-usda-license-for-poulvac-procerta-hvt-nd-ilt-vaccine-for-chickens\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/zoetis-receives-usda-license-for-poulvac-procerta-hvt-nd-ilt-vaccine-for-chickens\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Zoetis Receives USDA License for Poulvac\u00ae Procerta\u00ae HVT-ND-ILT Vaccine for Chickens\",\"datePublished\":\"2026-11-19T12:33:11+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/zoetis-receives-usda-license-for-poulvac-procerta-hvt-nd-ilt-vaccine-for-chickens\\\/\"},\"wordCount\":874,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/zoetis-receives-usda-license-for-poulvac-procerta-hvt-nd-ilt-vaccine-for-chickens\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20261118551715r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/zoetis-receives-usda-license-for-poulvac-procerta-hvt-nd-ilt-vaccine-for-chickens\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/zoetis-receives-usda-license-for-poulvac-procerta-hvt-nd-ilt-vaccine-for-chickens\\\/\",\"name\":\"Zoetis Receives USDA License for Poulvac\u00ae Procerta\u00ae HVT-ND-ILT Vaccine for Chickens - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/zoetis-receives-usda-license-for-poulvac-procerta-hvt-nd-ilt-vaccine-for-chickens\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/zoetis-receives-usda-license-for-poulvac-procerta-hvt-nd-ilt-vaccine-for-chickens\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20261118551715r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\",\"datePublished\":\"2026-11-19T12:33:11+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/zoetis-receives-usda-license-for-poulvac-procerta-hvt-nd-ilt-vaccine-for-chickens\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/zoetis-receives-usda-license-for-poulvac-procerta-hvt-nd-ilt-vaccine-for-chickens\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/zoetis-receives-usda-license-for-poulvac-procerta-hvt-nd-ilt-vaccine-for-chickens\\\/#primaryimage\",\"url\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20261118551715r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\",\"contentUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20261118551715r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/zoetis-receives-usda-license-for-poulvac-procerta-hvt-nd-ilt-vaccine-for-chickens\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Zoetis Receives USDA License for Poulvac\u00ae Procerta\u00ae HVT-ND-ILT Vaccine for Chickens\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Zoetis Receives USDA License for Poulvac\u00ae Procerta\u00ae HVT-ND-ILT Vaccine for Chickens - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/zoetis-receives-usda-license-for-poulvac-procerta-hvt-nd-ilt-vaccine-for-chickens\/","og_locale":"en_US","og_type":"article","og_title":"Zoetis Receives USDA License for Poulvac\u00ae Procerta\u00ae HVT-ND-ILT Vaccine for Chickens - Market Newsdesk","og_description":"Zoetis Receives USDA License for Poulvac\u00ae Procerta\u00ae HVT-ND-ILT Vaccine for Chickens 3-in-1 vector vaccine expands disease-protection options for chickens, backed by Zoetis\u2019 comprehensive vaccine portfolio and specialized expertise\u00a0 What it protects against: Poulvac\u00ae Procerta\u00ae HVT-ND-ILT is designed to protect chickens against Marek\u2019s disease (MD), Newcastle disease (ND) and infectious laryngotracheitis (ILT). 1 Why it matters: The USDA license adds a new option for veterinarians and poultry producers to consider when developing flock-health programs. PARSIPPANY, N.J.&#8211;(BUSINESS WIRE)&#8211;Zoetis Inc. (NYSE: ZTS) today announced that the U.S. Department of Agriculture (USDA) has licensed Poulvac\u00ae Procerta\u00ae HVT-ND-ILT, a vector vaccine for chickens. The license marks an important milestone in Zoetis\u2019 continued investment and industry leadership in poultry health, disease protection, and innovation. Poulvac Procerta &hellip; Continue reading \"Zoetis Receives USDA License for Poulvac\u00ae Procerta\u00ae HVT-ND-ILT Vaccine for Chickens\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/zoetis-receives-usda-license-for-poulvac-procerta-hvt-nd-ilt-vaccine-for-chickens\/","og_site_name":"Market Newsdesk","article_published_time":"2026-11-19T12:33:11+00:00","og_image":[{"url":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20261118551715r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"4 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/zoetis-receives-usda-license-for-poulvac-procerta-hvt-nd-ilt-vaccine-for-chickens\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/zoetis-receives-usda-license-for-poulvac-procerta-hvt-nd-ilt-vaccine-for-chickens\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Zoetis Receives USDA License for Poulvac\u00ae Procerta\u00ae HVT-ND-ILT Vaccine for Chickens","datePublished":"2026-11-19T12:33:11+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/zoetis-receives-usda-license-for-poulvac-procerta-hvt-nd-ilt-vaccine-for-chickens\/"},"wordCount":874,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/zoetis-receives-usda-license-for-poulvac-procerta-hvt-nd-ilt-vaccine-for-chickens\/#primaryimage"},"thumbnailUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20261118551715r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/zoetis-receives-usda-license-for-poulvac-procerta-hvt-nd-ilt-vaccine-for-chickens\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/zoetis-receives-usda-license-for-poulvac-procerta-hvt-nd-ilt-vaccine-for-chickens\/","name":"Zoetis Receives USDA License for Poulvac\u00ae Procerta\u00ae HVT-ND-ILT Vaccine for Chickens - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/zoetis-receives-usda-license-for-poulvac-procerta-hvt-nd-ilt-vaccine-for-chickens\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/zoetis-receives-usda-license-for-poulvac-procerta-hvt-nd-ilt-vaccine-for-chickens\/#primaryimage"},"thumbnailUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20261118551715r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","datePublished":"2026-11-19T12:33:11+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/zoetis-receives-usda-license-for-poulvac-procerta-hvt-nd-ilt-vaccine-for-chickens\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/zoetis-receives-usda-license-for-poulvac-procerta-hvt-nd-ilt-vaccine-for-chickens\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/zoetis-receives-usda-license-for-poulvac-procerta-hvt-nd-ilt-vaccine-for-chickens\/#primaryimage","url":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20261118551715r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","contentUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20261118551715r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en"},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/zoetis-receives-usda-license-for-poulvac-procerta-hvt-nd-ilt-vaccine-for-chickens\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Zoetis Receives USDA License for Poulvac\u00ae Procerta\u00ae HVT-ND-ILT Vaccine for Chickens"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/1022526","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=1022526"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/1022526\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=1022526"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=1022526"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=1022526"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}